Post-transcriptional Modifications Contribute to the Upregulation of Cyclin D2 in Multiple Myeloma

Irena Misiewicz-Krzeminska1, María E Sarasquete2, Carolina Vicente-Dueñas3

  • 1Centro de Investigacion del Cancer-IBMCC (USAL-CSIC), Salamanca, Spain. Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain. National Medicines Institute, Warsaw, Poland.

Abstract

Insights

Shortened CCND2 mRNA 3'UTRs in multiple myeloma lead to altered miRNA regulation and increased gene expression. This occurs via alternative polyadenylation, impacting cancer progression.

Area of Science:

  • Molecular Biology
  • Oncology
  • Gene Regulation

Background:

  • Dysregulation of D-cyclin genes is common in multiple myeloma.
  • Mechanisms of CCND2 (Cyclin D2) upregulation in multiple myeloma are not fully understood.
  • Post-transcriptional regulation via microRNAs (miRNAs) is a potential factor.

Purpose of the Study:

  • To investigate the role of miRNA interactions with CCND2 3 e202UTR binding sites in CCND2 overexpression.
  • To explore the impact of 3 e202UTR length variations on CCND2 regulation in multiple myeloma.
  • To elucidate the mechanisms behind CCND2 upregulation in multiple myeloma.

Main Methods:

  • Analysis of miRNA-mRNA interactions using 3 e202UTR-luciferase plasmid assays.
  • Detection and characterization of CCND2 mRNA isoforms using qRT-PCR, Northern blot, mRNA FISH, and 3 e202RACE-PCR.
  • Study included 11 myeloma cell lines and 45 primary myeloma samples.

Main Results:

  • Short CCND2 mRNA isoforms with truncated 3 e202UTRs were detected in multiple myeloma cells.
  • Alternative polyadenylation was identified as the cause of CCND2 3 e202UTR length variations.
  • Shorter CCND2 mRNA isoforms correlated with higher CCND2 expression and reduced miRNA binding sites.
  • Cyclin D1 and D3 overexpression influenced CCND2 polyadenylation, suggesting a regulatory role.

Conclusions:

  • CCND2 3 e202UTR shortening significantly impacts miRNA-dependent regulation of CCND2 in multiple myeloma.
  • Alternative polyadenylation of CCND2 contributes to its overexpression in multiple myeloma.
  • Findings highlight a novel mechanism of gene regulation in multiple myeloma progression.

Related Concept Videos

Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
7.1K
Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
137.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K